Literature DB >> 15739901

Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study.

A Riedel1, C S Leopold.   

Abstract

The aim of this study was to investigate the degradation of the acid-labile proton-pump-inhibitor omeprazole in organic polymer solutions and aqueous dispersions of enteric coating polymers by UV spectroscopy. Furthermore, data were compared with those obtained in a previous HPLC study. For comparative purposes the cationic Eudragit RS 100 and the monomeric acid acetic acid were included in this study. The discolorations of degraded omeprazole solutions were analysed by VIS spectroscopy. UV-VIS spectra were recorded after preparation of the solutions and after 180 min of storage. The change of absorption was calculated as the difference of the absorption values at 305 nm. Degradation of omeprazole depends on the amount of acidic groups in the polymer structure. This decomposition manifests itself in a shifting of the absorption maximum to lower wavelengths and a decrease of absorption intensity. UV-VIS spectroscopy was used to determine the extent of degradation induced by enteric polymers. A good correlation of these results with previous HPLC data was found when excluding UV absorbing polymers. Nevertheless, values obtained by UV-VIS spectroscopy were always lower than those obtained by HPLC. For evaluation of the discoloration of degraded omeprazole solutions, VIS spectroscopy is a simple and fast method.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15739901

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  A comprehensive development strategy in buccal drug delivery.

Authors:  Ana Figueiras; Alberto A C C Pais; Francisco J B Veiga
Journal:  AAPS PharmSciTech       Date:  2010-11-30       Impact factor: 3.246

2.  Effect of Elevated pH on the Commercial Enteric-Coated Omeprazole Pellets Resistance: Patent Review and Multisource Generics Comparison.

Authors:  Valentyn Mohylyuk; Anna Yerkhova; Marina Katynska; Vitaliy Sirko; Kavil Patel
Journal:  AAPS PharmSciTech       Date:  2021-06-22       Impact factor: 3.246

3.  Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.

Authors:  Yu Fang; Guozheng Wang; Rong Zhang; Zhihua Liu; Zhenghua Liu; Xiaohui Wu; Deying Cao
Journal:  AAPS PharmSciTech       Date:  2014-03-05       Impact factor: 3.246

4.  Erroneous formulation of delayed-release omeprazole capsules: alert for importing countries.

Authors:  Mohammad Sofiqur Rahman; Naoko Yoshida; Hirohito Tsuboi; Tep Keila; Tey Sovannarith; Heng Bun Kiet; Eav Dararth; Theingi Zin; Tsuyoshi Tanimoto; Kazuko Kimura
Journal:  BMC Pharmacol Toxicol       Date:  2017-05-03       Impact factor: 2.483

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.